The synergy of AZD6738 and 5-FU in a p53-mutated colorectal cancer model is mediated by AZD6738’s inhibition of 5-FU-induced G2/M checkpoint activation, enhanced apoptosis, and increased DNA damage, reducing cell survival (Wichert et al. 2024). This evidence concerns the gene TP53 and colorectal cancer.